Ashleigh Furlong
Health Reporter at Bloomberg News
Health reporter @bloomberg. Previously @POLITICOEurope, @ResFortnight and @GroundUp_News. Views my own. Send tips to [email protected].
Articles
-
5 days ago |
bloomberglinea.com.br | Julia Janicki |Ashleigh Furlong |Clara Hernanz Lizarraga |Rodrigo Orihuela
Bloomberg — Nas últimas semanas, as grandes empresas farmacêuticas dirigiram algumas palavras de baixo calão aos países europeus, inclusive chamando o Reino Unido de “não investível” e alertando que a região como um todo está perdendo rapidamente sua vantagem para a China.
-
1 week ago |
bloomberg.com | Ashleigh Furlong
The GSK headquarters in London. (Bloomberg) -- GSK Plc’s blood cancer drug Blenrep has won approval from the UK medicines regulator, opening the door to the return of a treatment that was withdrawn from the market about two years ago. In a boost for the British drugmaker, the UK is the first country to authorize Blenrep, in combination with other oncology drugs, for some patients with multiple myeloma, an incurable blood cancer, after they have received one previous treatment.
-
1 week ago |
bloomberglinea.com | Ashleigh Furlong |Clara Hernanz Lizarraga |Rodrigo Orihuela |Julia Janicki
Bloomberg — En las últimas semanas, las grandes farmacéuticas han dirigido duras críticas a los países europeos, calificando al Reino Unido de “inviable” y advirtiendo de que la región en su conjunto está perdiendo rápidamente su ventaja frente a China.
-
1 week ago |
news.bloomberglaw.com | Ashleigh Furlong
Tariffs on pharmaceuticals would hurt patients and drugs should be exempt from these levies, AstraZeneca Plc’ Chairman Michel Demaré said. US President Donald Trump has warned that tariffs on pharmaceutical companies — which weren’t part of the so-called reciprocal tariffs he imposed and then paused — are imminent.
-
1 week ago |
news.bloombergtax.com | Ashleigh Furlong
Tariffs on pharmaceuticals would hurt patients and drugs should be exempt from these levies, AstraZeneca Plc’ Chairman Michel Demaré said. US President Donald Trump has warned that tariffs on pharmaceutical companies — which weren’t part of the so-called reciprocal tariffs he imposed and then paused — are imminent.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →X (formerly Twitter)
- Followers
- 4K
- Tweets
- 3K
- DMs Open
- Yes
The pharma industry is flocking to Spain. We wanted to know why. The answer was fascinating: Tax breaks; cheap, good quality science and a government bending over backwards to attract investment. Story W/@clarahenz, @rorihuela, @jhjanicki Gift link: https://t.co/3yNugmwCcF
RT @basteiro: Cómo España se ha convertido en uno de los países favoritos (de todo el mundo) para las farmacéuticas https://t.co/rNj8J8eT1…
RT @AntonySguazzin: Progress in combating HIV/AIDS may be about to reverse as the Trump administration guts funding @ashleighfurlong @janic…